Laboratorios Farmacéuticos Rovi SA (1ROVI)
MTA
58.15
0.00 (0.00%)
Closed
Oct 2, 2026
Day's Range
58.1558.15
52 wk Range
55.0576.75
Financial Statements - 1ROVI - Laboratorios Farmacéuticos Rovi SA
Revenue
743.48M▼ 2.7%
Net Income
140.36M▲ 2.5%Net Margin 18.9%
EBITDA
216.80M▲ 4.4%
Free Cash Flow
119.26M▲ 56.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 743.48M | 763.74M |
| Cost of Goods | 260.79M | 285.40M |
| Gross Profit | 482.68M | 478.34M |
 Operating Expense | - | - |
| Operating Income | 185.78M | 179.54M |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | 183.26M | 177.69M |
| Income Tax | 42.89M | 40.81M |
| Net Income | 140.36M | 136.87M |
| EPS Basic | 2.75 | 2.676097 |
| EPS Diluted | 2.75 | 2.676097 |
| Basic Shares Outstanding | 51.14M | 51.14M |
| Diluted Shares Outstanding | 51.14M | 51.14M |
| Ebit | 185.82M | 179.67M |
| Ebitda | 216.80M | 207.61M |
| Net Income Continuous Operations | 183.26M | 177.69M |
| Minority Interests | 78K | 5K |
| Preferred Stock Dividends | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
